Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.51 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | LAP3 | P28838 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | GNPAT | O15228 | 1/20 | 0.47 |
| ▸ | RRM1 | P23921 | 1/20 | 0.46 |
| ▸ | RRM2 | P31350 | 1/20 | 0.46 |
| ▸ | RRM2B | Q7LG56 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29414957 | 1.00 | MME (0.51) | MMEFOLH1ALDH1A1MAPTLAP3 | |
| SCHEMBL30628180 | 0.98 | MME (0.50) | MMEFOLH1ALDH1A1MAPTLAP3 | |
| SCHEMBL29630515 | 0.95 | MME (0.50) | MMEFOLH1ALDH1A1MAPTLAP3 | |
| SCHEMBL29592701 | 0.95 | MME (0.50) | MMEFOLH1ALDH1A1MAPTLAP3 | |
| SCHEMBL29870736 | 0.95 | MME (0.53) | MMEFOLH1ALDH1A1MAPTSLC7A5 | |
| SCHEMBL30956311 | 0.94 | BACE1 (0.48) | MMEFOLH1ALDH1A1MAPTLAP3 | |
| SCHEMBL29350942 | 0.94 | MME (0.51) | MMEFOLH1ALDH1A1MAPTLAP3 | |
| SCHEMBL29350546 | 0.93 | MME (0.48) | MMEFOLH1ALDH1A1MAPTLAP3 | |
| SCHEMBL29349637 | 0.92 | MME (0.53) | MMEFOLH1ALDH1A1MAPTLAP3 | |
| SCHEMBL7429984 | 0.92 | MME (0.55) | MMEALDH1A1MAPTLAP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |